FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $66,000 | +37.5% | 20,030 | +25.0% | 0.00% | 0.0% |
| Q3 2019 | $48,000 | +23.1% | 16,030 | -3.8% | 0.00% | +100.0% |
| Q2 2019 | $39,000 | -39.1% | 16,655 | -2.9% | 0.00% | -66.7% |
| Q1 2019 | $64,000 | +36.2% | 17,155 | +29.4% | 0.00% | +50.0% |
| Q4 2018 | $47,000 | -36.5% | 13,255 | +2.3% | 0.00% | -50.0% |
| Q3 2018 | $74,000 | +42.3% | 12,955 | +25.7% | 0.00% | +33.3% |
| Q2 2018 | $52,000 | +52.9% | 10,305 | +54.3% | 0.00% | +50.0% |
| Q1 2018 | $34,000 | – | 6,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,293,177 | $4,643,000 | 4.08% |
| GREAT POINT PARTNERS LLC | 4,047,561 | $14,531,000 | 1.84% |
| Sio Capital Management, LLC | 1,151,510 | $4,134,000 | 1.51% |
| DAFNA Capital Management LLC | 808,000 | $2,901,000 | 1.44% |
| Diag Capital Management, LP | 146,432 | $960,000 | 1.10% |
| Perceptive Advisors | 4,661,824 | $15,850,000 | 0.60% |
| Eversept Partners, LP | 294,660 | $1,057,829 | 0.57% |
| Sofinnova Investments, Inc. | 832,293 | $2,987,000 | 0.37% |
| KNOTT DAVID M | 206,200 | $740,000 | 0.35% |
| Orbimed Advisors | 5,195,330 | $18,651,000 | 0.34% |